Tag results:

brain cancer

How Brains Fold: USU Team Wins NIH Grant to Study Cerebral Shaping

[Utah State University] Yu Huang, assistant professor of biological engineering, will receive $1.8 million from the National Institutes of Health to study cerebral morphology. Their goal is to better understand how a brain develops under spatial constraint and to uncover new insights into the spreading of brain cancer.

CREB Signaling Activity Correlates with Differentiation and Survival in Medulloblastoma

[Scientific Reports] Scientists observed that during normal cerebellar development, phosphorylated CREB was selectively expressed in differentiating cerebellar granule neuron progenitor (CGNP) cells.

Omniscient Neurotechnology Launches Quicktome™ Brain Mapping Platform for Neurosurgery after Regulatory Clearance in United States, Canada and Australia

[Omniscient Neurotechnology, Inc. (BusinessWire, Inc.)] Omniscient Neurotechnology, Inc. announced that it has received US FDA 510(k) clearance for Quicktome™, a digital brain mapping platform that allows neurosurgeons to visualize and understand a patient's brain networks prior to performing life-changing brain surgery.

Targeting the αv Integrin-TGF-β Axis Improves Natural Killer Cell Function against Glioblastoma Stem Cells

[Journal of Clinical Investigation] Researchers showed that glioblastoma stem cells, but not normal astrocytes, were sensitive to lysis by healthy allogeneic natural killer cells in vitro.

Targeting the αv Integrin-TGF-β Axis Improves Natural Killer Cell Function against Glioblastoma Stem Cells

[Journal of Clinical Investigation] The authors showed that glioblastoma stem cells, but not normal astrocytes, were sensitive to lysis by healthy allogeneic natural killer cells in vitro.

Brain Cancer Canada Funds Groundbreaking Glioblastoma Treatment Research

[Brain cancer Canada] Brain Cancer Canada turns awareness into action by emphatically supporting groundbreaking research into brain cancer treatment. The charity has made $100,000 available to Dr. Sheila Singh and her research group at McMaster University to target recurrent Glioblastomas (GBMs) with generous support from sponsors, including Scotia Wealth Management, Yamana Gold, and Hampton Securities.

Popular